Become A Featured Company

Virtual Psychedelics Conference Brings Together Over 100 Thought-Leaders, Researchers, Businesses & Investors 

Ryan Allway

April 9th, 2020

Policy

Microdose, The Green Light, and The Conscious Fund’s Virtual Psychedelics Conference will take place on April 14 through 15, 2020, bringing together leading scientists, researchers and executives across the nascent psychedelics industry to discuss drug development, regulation, ethics, investment and a wide range of other topics. Due to the current COVID19 social distancing measures, this conference format provides attendees with the unique ability to participate from the comforts of their homes, from anywhere around the world.

Sign up to attend the conference today and don’t miss the industry’s premiere event of the season—and use the code CFN20 to receive a 20% discount.

The two-day conference features keynotes by Robin Carhart-Harris on therapeutic mechanisms on April 14 and Dennis McKenna on lessons from a lifetime in psychedelics on April 15, as well as over 90 other speakers discussing specific topics and emerging trends in the industry.

The wide range of subject matters covered include:

  • Regulation & Law
  • Science
  • Technology
  • Ethics
  • Patient Experience
  • Venture Capital & Funding
  • Crossing Over from Cannabis
  • PTSD
  • CEO Panel
  • Holistic Wellness
  • Capital Markets
  • Beyond Mental Health
  • Whole Plant vs. Synthetic
  • Ibogaine & Addiction
  • Going Mainstream
  • The Mushroom
  • Communicating Psychedelics
  • Philanthropy

Panels and keynotes will run for 30 minutes with a 15-minute Q&A session afterwards. The conference will begin at 17:00 (GMT) / 12:00 (EST) / 10:00 (PST) each day. Attendees will be sent login and platform details on Monday the 13th of April. The whole conference will be recorded and made available to all ticket holders after the event, so that attendees can watch at their own leisure.

In addition to these speakers, premium ticket holders have access to one-on-one meetings with active investors pursuing opportunities in the space, researchers actively engaged in the space, and psychedelics companies. Calls will be scheduled between these parties at the end of the conference and all speakers and sponsors will be available for contact. If you would like to get in touch with any of the panelists before or after the event, you can reach out to Alex Krause – alex@alanaldous.com.

Sign up to attend the conference today and don’t miss the industry’s premiere event—and use the code CFN20 to receive a 20% discount.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading